000			01862 a2200565 4500
005			20250517121706.0
264		0	_c20170731
008			201707s 0 0 eng d
022			_a1546-170X
024	7		_a10.1038/nm.4204 _2doi
040			_aNLM _beng _cNLM
245	0	0	_aRecurrent MET fusion genes represent a drug target in pediatric glioblastoma. _h[electronic resource]
260			_bNature medicine _c11 2016
300			_a1314-1320 p. _bdigital
500			_aPublication Type: Journal Article
650	0	4	_aAdolescent
650	0	4	_aAdult
650	0	4	_aAnilides _xpharmacology
650	0	4	_aAnimals
650	0	4	_aBrain Neoplasms _xdrug therapy
650	0	4	_aCell Line, Tumor
650	0	4	_aChild
650	0	4	_aChild, Preschool
650	0	4	_aCrizotinib
650	0	4	_aDNA, Neoplasm
650	0	4	_aFemale
650	0	4	_aGlioblastoma _xdrug therapy
650	0	4	_aHumans
650	0	4	_aInfant
650	0	4	_aMale
650	0	4	_aMice
650	0	4	_aMice, SCID
650	0	4	_aMicrotubule-Associated Proteins _xgenetics
650	0	4	_aMitogen-Activated Protein Kinases
650	0	4	_aOncogene Proteins, Fusion _xgenetics
650	0	4	_aProtein Kinase Inhibitors _xpharmacology
650	0	4	_aProteins _xgenetics
650	0	4	_aProto-Oncogene Proteins c-met _xantagonists & inhibitors
650	0	4	_aPyrazoles _xtherapeutic use
650	0	4	_aPyridines _xtherapeutic use
650	0	4	_aQuinolines _xpharmacology
650	0	4	_aRNA, Messenger _xmetabolism
650	0	4	_aReceptor-Like Protein Tyrosine Phosphatases, Class 5 _xgenetics
650	0	4	_aSequence Analysis, DNA
650	0	4	_aSignal Transduction
650	0	4	_aXenograft Model Antitumor Assays
650	0	4	_aYoung Adult
773	0		_tNature medicine _gvol. 22 _gno. 11 _gp. 1314-1320
856	4	0	_uhttps://doi.org/10.1038/nm.4204 _zAvailable from publisher's website
999			_c26522414 _d26522414